|
FLUORIDE 31 (3) 1998, pp 143-148 |
International Society for Fluoride Research | Table of Contents |
Dhruva Patel and N J Chinoy Ahmedabad, India
SUMMARY: Sodium fluoride (5 mg/kg body weight) was effective from the 45th day of treatment in causing a significant decline in DNA and RNA levels of mice ovary and uterus, indicating alterations in nucleic acid and protein metabolism in these organs. The oestrus cycle was irregular with prolonged duration of the diestrus stage which in turn severely affected the fertility rate in treated mice.
The administration of amino acids glycine and glutamine, individually and in combination along with NaF, helped in maintaining the status quo of all parameters as compared to control, thus elucidating their ameliorative role.
Key words: Amino acids; DNA; Fertility; Mice; RNA; Sodium fluoride.
Tsutsui et al described genotoxic effects of fluoride.1 NaF has been reported to cause an increase in the frequency of Sister Chromatid Exchange (SCE) in human population of endemic areas of North Gujarat.2
Increased feeding of fluoride to animals and humans raises the fluoride concentration in maternal and fetal blood.3 Administration of 150-300 mg F/kg body weight blocked gonadotropin stimulation of rabbit ovary.4 Hanley et al reported maternal weight loss and fetotoxic effects of fluoride in white rabbits and rats exposed to 225 ppm of fluoride.5 Messer et al have attempted to link infertility and fluorosis.6 Reports from our laboratory have clearly elucidated alterations in carbohydrate and oxidative metabolisms and altered functions of some vital and reproductive organs in fluoridated female mice.7-9 However, the effects in the ovary and uterus due to fluoride are not yet fully explored.
In the light of earlier data the purpose of the present investigation was to evaluate the effects of fluoride on nucleic acid and protein levels in the ovary and uterus and the fertility impairment in mice under experimental fluorosis. The possible role of amino acids (glycine and glutamine) in the amelioration of fluoride induced toxicity was also investigated.
The animals used, exposures, protein levels and experimental protocol are the same as described earlier by Chinoy and Patel.9 The protein levels used in this study are also the same as given in Chinoy and Patel.9
Nucleic Acids:
The deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the ovary and uterus were first extracted in trichloroacetic acid (TCA) and the RNA levels were determined using orcinol as the colouring reagent by the method of Mejboum.10 The resulting colour was read at 670 nm on a Systronics Colorimeter 106 and expressed as µ moles/100 mg fresh tissue weight.
The DNA levels were estimated by the method of Giles and Meyer11 using diphenylamine as the colouring reagent and the OD of the resultant colour was read at 620 nm on a Systronics 106 Colorimeter and expressed as µ moles/100 mg fresh tissue weight.
Fertility Test: was assessed according to the WHO protocol MB-50.12
Cyclicity: The Oestrus cycle was recorded in normal and NaF treated mice, by observing the vaginal smear daily, for over a period of two months.
Statistics: For each biochemical estimation, a minimum of 6 to 8 replicates were carried out and the data was analyzed using Analysis of variance (ANOVA) followed by Scheff ’s test.
Deoxyribonucleic acid (DNA):
NaF treatment resulted in a significant suppression (P<0.001) of ovarian and uterine DNA levels. However, after administration of glycine and/or glutamine (group III, IV, V) the DNA levels were almost similar to those of control (Table 1), which implies a significant increase (P<0.001) as compared to the NaF treated group.
Ribonucleic acid (RNA):
NaF treatment (45, 60 days) caused significant (P<0.001) decline in ovarian and uterine RNA levels as compared to control, whereas, after administration of glycine and/or glutamine along with NaF (group III, IV, V) the ribonucleic acid levels were similar to those in the control mice (Table 2) which reveals a significant increase (P<0.001) as compared to the treated group.
DNA/RNA ratio:
The DNA/RNA ratio in uterus declined (P<0.05) after 45days and 60 days of treatment, whereas it increased (P<0.05) in the ovary. NaF treatment along with glycine and/or glutamine resulted in increase (P<0.05) in the DNA/RNA ratio in the uterus as compared to NaF treated group whereas in the ovary the ratio remained unaltered (Table 3).
RNA/Protein ratio:
A significant decline (P<0.001) in RNA/protein ratio occurred in the ovary after NaF treatment (45 and 60 days), while, no change was observed in uterus. After administration of glycine or glutamine along with NaF (group III and IV), the ratio was the same as in control (P<0.05). The levels were almost the same as control in group V in which animals were fed glycine and glutamine in combination with NaF (Table 4), implying a significant increase as compared to the NaF treated group.
Fertility rate :
Sodium fluoride treatment led to a significant decline (P<0.001) in fertility rate after 45 and 60 days of treatment. The fertility rate was less affected after ingestion of glycine or glutamine alone and in combination along with NaF (Table 5) than in NaF treatment alone (group II).
Cyclicity:
The cyclicity of NaF treated animals was disturbed. The cycles were irregular and prolonged. However, in groups III, IV and V regular cycles were observed but their duration was extended (Table 5).
|
in uterus and ovary of control and treated groups | ||||
| Uterus | Ovary | |||
| Groups | 45 days | 60 days | 45 days | 60 days |
| Control | 886.34 ± 20.2 | 894.30 ± 18.1 | 1053 ± 36.3 | 1002.0 ± 21.2 |
| NaF | 484.79 ± 17.9* | 408.28 ± 16.6* | 658 ± 17.0* | 599.0 ± 18.2* |
| NaF+Glycine | 807.57 ± 12.2* | 907.72 ± 18.2* | 923 ± 16.3* | 976.0 ± 19.1* |
| NaF + Glutamine | 794.15 ± 19.9* | 865.28 ± 15.1* | 936 ± 19.9* | 941.44 ± 16.6* |
| NaF+Glycine + Glutamine |
907.12 ± 24.8* | 974.56 ± 14.2* | 1024 ± 32.6* | 1056.0 ± 21.9* |
| Values are Mean + Std Error * P < 0.001 | ||||
| TABLE 1B. DNA ANOVA | ||||||
| Source of variation |
SS | df | MSS | f(cal) | f(tab) | P value |
| Uterus Groups Residual |
1104058.00 20732.00 |
8 18 |
138007.00 1151.00 |
119.80 |
3.71 |
<0.001 |
| Ovary Groups Residual |
849933.60 41481.00 |
8 18 |
106241.00 2304.00 |
46.10 |
3.71 |
<0.001 |
| SS = Sum of squares df = Degrees of freedom MSS = Mean sum of squares | ||||||
|
TABLE 2A. RNA levels (µ moles/100 mg fresh tissue weight) in uterus and ovary of control and treated groups | ||||
| Uterus | Ovary | |||
| Groups | 45 days | 60 days | 45 days | 60 days |
| Control | 151.52 ± 6.2 | 149 ± 7.6 | 221.51 ± 11.1 | 208 ± 19.6 |
| NaF | 112.51 ± 5.9** | 99.21 ± 7.9*** | 104.19 ± 11.3*** | 98.86 ± 10.0*** |
| NaF+Glycine | 130.93 ± 6.7* | 117.67 ± 8.2** | 152.86 ± 8.7** | 173.66 ± 12.1*** |
| NaF+Glutamine | 119.13 ± 2.3NS | 113.48 ± 4.2** | 142.97 ± 10.2** | 168.71 ± 10.9*** |
| NaF+Glycine + Glutamine |
134.8 ± 9.2* | 129.98 ± 7.6*** | 176 ± 8.6** | 188.82 ± 11.3*** |
| Values are Mean ± Std Error ***P < 0.001 **P < 0.01 *P < 0.05 | ||||
| TABLE 2B. RNA ANOVA | ||||||
| Source of variation |
SS | df | MSS | f(cal) | f(tab) | P value |
| Uterus | ||||||
| Groups | 8280.65 | 8 | 1035.00 | 5.57 | 3.71 | <0.001 |
| Residual | 3342.00 | 18 | 185.00 | |||
| Ovary | ||||||
| Groups | 42369.30 | 8 | 5296.00 | 17.00 | 3.71 | <0.001 |
| Residual | 5604.60 | 18 | 311.00 | |||
| SS = Sum of squares df = Degrees of freedom MSS = Mean sum of squares | ||||||
| TABLE 3A. DNA/RNA ratio in uterus and ovary of control and treated groups | ||||
| Uterus | Ovary | |||
| Groups | 45 days | 60 days | 45 days | 60 days |
| Control | 5.76 ± 0.4 | 5.90 ± 0.3 | 4.77 ± 1.1 | 4.54 ± 0.6 |
| NaF | 4.29 ± 0.3* | 4.17 ± 1.2* | 6.39 ± 0.3* | 6.08 ± 1.4* |
| NaF+Glycine | 6.38 ± 0.9* | 7.71 ± 0.6* | 6.23 ± 1.9* | 5.75 ± 0.9* |
| NaF + Glutamine | 7.10 ± 0.6* | 7.60 ± 0.1* | 6.71 ± 2.0* | 6.55 ± 1.3* |
| NaF+Glycine + Glutamine |
6.93 ± 0.4* | 7.35 ± 0.3* | 5.81 ± 1.4* | 5.60 ± 0.8* |
| Values are Mean ± Std Error *P < 0.05 | ||||
| TABLE 3B. DNA/RNA Ratio ANOVA | ||||||
| Source of variation |
SS | df | MSS | f(cal) | f(tab) | P value |
| Uterus | ||||||
| Groups | 62.55 | 8 | 7.82 | 7.28 | 3.26 | <0.05 |
| Residual | 29.00 | 27 | 1.07 | |||
| Ovary | ||||||
| Groups | 16.07 | 8 | 2.01 | 4.17 | 3.71 | <0.05 |
| Residual | 8.67 | 18 | 0.48 | |||
| SS = Sum of squares df = Degrees of freedom MSS = Mean sum of squares | ||||||
| TABLE 4A. RNA/Protein ratio in uterus and ovary of control and treated groups | ||||
| Uterus | Ovary | |||
| Groups | 45 days | 60 days | 45 days | 60 days |
| Control | 10.53 ± 0.32 | 10.41 ± 2.10NS | 18.22 ± 0.90 | 19.6 ± 0.72 |
| NaF | 11.49 ± 0.61NS | 10.88 ± 1.00 NS | 13.10 ± 1.21** | 13.49 ± 0.67** |
| NaF+Glycine | 10.10 ± 0.77NS | 8.94 ± 0.96 NS | 14.14 ± 0.62* | 15.03 ± 0.62* |
| NaF + Glutamine | 8.57 ± 0.31NS | 8.85 ± 0.62 NS | 12.96 ± 0.81* | 13.92 ± 1.62* |
| NaF+Glycine + Glutamine |
9.26 ± 0.40NS | 9.05 ± 0.91 NS | 16.60 ± 1.30** | 16.20 ± 1.42** |
|
Values are Mean ± Std Error
*P < 0.05
**P < 0.001 For protein levels in ovary and uterus see Part I (reference no. 9) | ||||
| TABLE 4B. RNA/Protein Ratio ANOVA | ||||||
| Source of variation |
SS | df | MSS | f(cal) | f(tab) | P value |
| Uterus | ||||||
| Groups | 30.29 | 8 | 3.78 | 1.86 | 3.71 | NS |
| Residual | 36.47 | 18 | 2.02 | |||
| Ovary | ||||||
| Groups | 143.37 | 8 | 17.92 | 7.57 | 3.71 | <0.001 |
| Residual | 42.57 | 18 | 2.36 | |||
| SS = Sum of squares df = Degrees of freedom MSS = Mean sum of squares NS = Non significant | ||||||
| TABLE 5. Fertility rate (%) and implantation sitesof treated and control groups of mice | ||||||||
| No. of females mated/ No. of females pregnant |
Fertility rate (%) |
No. of implantation sites |
Cyclicity | |||||
| 45 days | 60 days | 45 days | 60 days | 45 days | 60 days | 45 days | 60 days | |
| Control | 10/10 | 10/10 | 100 | 100 | 12.8± 0.9 | 12.5± 0.7 | Regular | Regular |
| NaF | 10/6 | 10/2 | 60 | 20 | 3.2± 0.5** | 1.5± 0.5** | Irregular | Irregular |
| NaF+Glycine | 10/9 | 10/9 | 90 | 90 | 8.5± 1.4* | 6.5± 0.3 | Regular | Regular |
| NaF+Glutamine | 10/9 | 10/9 | 90 | 90 | 8.0± 1.3* | 7.0± 1.1* | Regular | Regular |
| NaF+Glycine + Glutamine |
10/10 | 10/10 | 100 | 100 | 9.0± 1.5** | 9.0± 1.2** | Regular | Regular |
|
The oestrus cycle was found to be regular but duration of cycle was extended. Females:Males used in ratio of 2:1. **P< 0.001 *P<0.01 At least 3 sets done for each group and mean values are presented. | ||||||||
Several human conditions including aging, cancer and arteriosclerosis have been associated with DNA damage and its misrepair.13 Fluoride has been reported to cause depression in DNA and RNA synthesis in cultured cells.14 In the present study, the DNA and RNA concentrations in the ovary and uterus were significantly decreased, which could be due to a decrease in their synthesis or an alteration in their metabolism. Earlier reports have also revealed that fluoride ingestion in rabbits resulted in a decrease in DNA and RNA levels in the ovary15 in corroboration with the present data. The inhibition of DNA and RNA synthesis may result in delayed mitotic and meiotic cycles including chromosomal breakages.16 Studies on fluorotic human population in endemic areas of North Gujarat have shown an increase in frequency of sister chromatid exchange as compared to the control indicating that fluoride might have a genotoxic effect.2
The DNA/RNA ratio declined in the uterus, whereas it remained unaltered in the ovary. This decrease might be due to a significant decline in RNA concentration.
The DNA/Protein ratio was also significantly decreased in the ovary and uterus which could be related to the significant decline in protein levels. Thus it is likely that the process of transcription and translation would be affected in NaF treated mice. Further detailed studies on DNA repair mechanism on DNA polymerase activity as well as other enzymes involved in nucleic acid synthesis and metabolism are called for in the future.
In the present study, NaF treatment (60 days) induced complete loss of fertility and absence of implantation sites in NaF treated females when mated with control males. The loss of fertility might be due to irregularity in cyclicity related to altered hormone levels.
The present study thus elucidates that NaF brought about alterations in ovarian and uterine nucleic acid metabolism and had effects on reproduction. Since the structure and internal milieu of the uterus is maintained by priming of estrogen and action of progesterone, it is necessary to study the levels of these hormones and the ultrastructural changes in the ovary and uterus.
The present study also elucidates that supplementation of amino acids (glycine and/or glutamine) along with NaF manifested amelioration in all NaF induced effects, which was more pronounced with the combined administration.
Acknowledgement: The financial support provided by the Council of Scientific and Industrial Research (CSIR), New Delhi, to one of the authors (DP) is gratefully acknowledged.
Sheth FJ, Multani AS, Chinoy NJ. Sister chromatid exchanges: A study in fluorotic individuals of North Gujarat. Fluoride 27 (4) 215-219 1994.
| FLUORIDE 31 (3) 1998, pp 143-148 |
International Society for Fluoride Research | |
|
Home |
Table of Contents |
ISFR Board |
Subscription Submissions | Announcements | Authors | Subject Index |